Dan Roden
Director, Oates Institute for Experimental Therapeutics · Vanderbilt University Medical Center
Credentials: · · · · ·
History
PresentOates Institute for Experimental Therapeutics Center · Vanderbilt University Medical Center
PresentOates Institute for Experimental Therapeutics Center · Vanderbilt Univ Sch of Med
- 1977–1978
MUHC
- 1974–1977
McGill University Hospital
Research
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Case report · New England Journal of Medicine · 2016 · 1,890 citations
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Nature · 2021 · 1,859 citations
Drug-induced prolongation of the QT interval
Review · New England Journal of Medicine · 2004 · Sole author · 1,478 citations
155 papers · 12 as a resident
84 papers · 7 as a resident
82 papers · 8 as a fellow
74 papers
62 papers · 14 as a fellow
58 papers
56 papers
48 papers
Grants
- 2016–2031
VGM: Vanderbilt Genomic Medicine Training Program
National Human Genome Research Institute · T32
PI · $1.5M · Vanderbilt University Medical Center
- 2024–2029
Vanderbilt Genomic Learning Health System Clinical Site
National Human Genome Research Institute · U01
Contact PI · $2.2M · Vanderbilt University Medical Center
- 2022–2027
All of Us Research Program Data and Research Center
NIH Office of the Director · OT2
PI · $210.4M · Vanderbilt University Medical Center
- 2022–2027
Systematically Mapping Variant Effects for Cardiovascular Genes
National Heart, Lung, and Blood Institute · R01
Contact PI · $8.1M · Vanderbilt University Medical Center
Clinical trials
- 2015–2020
Electronic Medical Records and Genomics (eMERGE) Phase III
Principal investigator · Completed
Vanderbilt University Medical Center
- 2026–2030